Accession Number:

ADA386967

Title:

Regulation of ErbB-2 and Signaling by CHK and Csk Tyrosine Kinases in Breast Cancer

Descriptive Note:

Annual rept. 23 Apr 1999-22 Apr 2000

Corporate Author:

BETH ISRAEL DEACONESS MEDICAL CENTER BOSTON MA

Personal Author(s):

Report Date:

2000-05-01

Pagination or Media Count:

12.0

Abstract:

The HER-2neuc-erbB2 and Src family members are implicated in the pathogenesis of breast cancer. In this study, we have examined the role of CHK kinase in suppressing the cell transformation mediated by ErbB-2 and src kinases. We generated stable transfected human breast carcinoma MCF-7 cells overexpressing CHK either active or inactive kinase-dead. We showed that overexpression of active CHK but not inactive CHK inhibited in vitro MCF7 cells growth, transformation 5-fold and invasion 24 to 33 induced upon HRG stimulation. In addition, in vitro Lyn tyrosine kinase activity was inhibited 5-fold and entry into mitosis was delayed. Furthermore, in vivo tumor growth of MCF-7 cells transfected with active CHK but not inactive CHK and grafted in nude mice was significantly inhibited 97 to 100 compared to untransfected MCF-7 cells P 0.05 and P 0.03 for the two clones of MCF-7 cells transfected with active CHK that were tested. In conclusion, our data strongly support the role of CHK as a novel tumor suppressor gene for human breast cancer, acting through downregulation of Lyn kinase activity and regulation of the S-phase of the cell cycle.

Subject Categories:

  • Anatomy and Physiology
  • Medicine and Medical Research

Distribution Statement:

APPROVED FOR PUBLIC RELEASE